Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2008 1
2010 1
2011 1
2012 1
2013 3
2015 2
2017 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.
Prabowo SA, Gröschel MI, Schmidt ED, Skrahina A, Mihaescu T, Hastürk S, Mitrofanov R, Pimkina E, Visontai I, de Jong B, Stanford JL, Cardona PJ, Kaufmann SH, van der Werf TS. Prabowo SA, et al. Among authors: visontai i. Med Microbiol Immunol. 2013 Apr;202(2):95-104. doi: 10.1007/s00430-012-0278-6. Epub 2012 Nov 10. Med Microbiol Immunol. 2013. PMID: 23143437 Review.
A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010.
Heyman P, Ceianu CS, Christova I, Tordo N, Beersma M, João Alves M, Lundkvist A, Hukic M, Papa A, Tenorio A, Zelená H, Essbauer S, Visontai I, Golovljova I, Connell J, Nicoletti L, Van Esbroeck M, Gjeruldsen Dudman S, Aberle SW, Avšić-Županc T, Korukluoglu G, Nowakowska A, Klempa B, Ulrich RG, Bino S, Engler O, Opp M, Vaheri A. Heyman P, et al. Among authors: visontai i. Euro Surveill. 2011 Sep 8;16(36):19961. doi: 10.2807/ese.16.36.19961-en. Euro Surveill. 2011. PMID: 21924118 Free article.
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.
van Doorn E, Liu H, Ben-Yedidia T, Hassin S, Visontai I, Norley S, Frijlink HW, Hak E. van Doorn E, et al. Among authors: visontai i. Medicine (Baltimore). 2017 Mar;96(11):e6339. doi: 10.1097/MD.0000000000006339. Medicine (Baltimore). 2017. PMID: 28296763 Free PMC article. Clinical Trial.
12 results